ESSA Pharma to Present at the JonesHealthcare Seaside Summit
ESSA Pharma to Present at the JonesHealthcare Seaside Summit
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, July 8, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will present at the JonesHealthcare Seaside Summit on Monday, July 15, 2024 at 11:00 a.m. PT.
2024年7月8日，加利福尼亚州南旧金山和不列颠哥伦比亚省温哥华 /美通社/ --ESSA Pharma Inc.（以下简称公司）（纳斯达克：EPIX），一家临床阶段的药物公司，专注于开发治疗前列腺癌的新型疗法，今天宣布，公司将于2024年7月15日星期一上午11:00太平洋时间在JonesHealthcare Seaside Summit上进行演讲。
David R. Parkinson, President and Chief Executive Officer, will host the presentation and will also participate in a panel discussion titled "Innovations and Challenges in Prostate Cancer" at 9:00 a.m. PT.
演讲将由总裁兼首席执行官David R. Parkinson主持，并将在太平洋时间上午9:00参加标题为“前列腺癌创新与挑战”的小组讨论。
A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at . Following the event, the webcast will be archived on the ESSA website for 90 days. The panel, "Innovations and Challenges in Prostate Cancer," will not be webcast.
演示的现场网络广播可以在ESSA网站的投资者/事件和演示文稿部分访问。活动结束后，网络广播将在ESSA网站上存档90天。小组“前列腺癌的创新与挑战”不会进行网络广播。
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit , and follow us on X and LinkedIn.
关于ESSA Pharma Inc。
ESSA是一家临床阶段的制药公司，专注于开发治疗前列腺癌患者的新型专有疗法。有关更多信息，请访问网站，并在X和领英上关注我们。
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
[email protected]
联系方式
ESSA Pharma Inc。
彼得·维尔希克（Peter Virsik），首席运营官
778.331.0962
[email protected]
Investors and Media:
Argot Partners
212.600.1902
[email protected]
投资者和媒体:
阿哥特合伙人。
212.600.1902
[email protected]
SOURCE ESSA Pharma Inc
来源：ESSA Pharma Inc